Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
34.80
+0.15 (0.43%)
Jun 4, 2025, 12:28 PM - Market open

Vaxcyte Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
4,48910,2035,9763,7871,2561,354
Upgrade
Market Cap Growth
-34.34%70.74%57.79%201.58%-7.24%-
Upgrade
Enterprise Value
2,8858,0504,7243,445978957
Upgrade
Last Close Price
34.6581.8662.8047.9523.7926.57
Upgrade
PB Ratio
1.403.094.823.974.423.91
Upgrade
P/TBV Ratio
1.403.094.823.974.423.91
Upgrade
Debt / Equity Ratio
0.030.020.020.020.06-
Upgrade
Quick Ratio
17.2412.617.4623.088.618.25
Upgrade
Current Ratio
17.7012.767.5423.268.938.30
Upgrade
Return on Equity (ROE)
-19.66%-20.41%-36.67%-36.12%-31.78%-44.58%
Upgrade
Return on Assets (ROA)
-14.53%-14.47%-24.23%-21.82%-18.07%-24.42%
Upgrade
Return on Capital (ROIC)
-15.00%-15.32%-26.10%-22.82%-20.04%-27.97%
Upgrade
Earnings Yield
-11.40%-4.55%-6.73%-5.90%-7.97%-6.59%
Upgrade
FCF Yield
-13.28%-5.60%-6.10%-4.66%-10.19%-3.53%
Upgrade
Buyback Yield / Dilution
-23.64%-25.57%-49.75%-24.95%-75.73%-678.53%
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q